# Aravindhan Veerapandiyan, M.D. – FDA Inspection, Sep 25, 2026

Source: https://www.keypedia.com/records/fda_inspections/aravindhan-veerapandiyan-md/97321bc6-ae38-41ac-b775-1801433cb504
Source feed: FDA_Inspections

> FDA inspection 1337504 of Aravindhan Veerapandiyan, M.D., September 25, 2026. 1 citation under 21 CFR part 312. Form 483 issued.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1337504
- Company Name: Aravindhan Veerapandiyan, M.D.
- Inspection Date: 2026-09-25
- Project Area: Bioresearch Monitoring
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: Dallas District Office
- Citation Count: 1

## Related Officers

- [Company Rep](https://www.keypedia.com/people/stephanie-barragan/fc1bc901-1467-4fdd-bee3-f87f2db3a1fa)

Company: https://www.keypedia.com/companies/aravindhan-veerapandiyan-md/598e26df-cfe6-426d-a436-9e2404312697

Office: https://www.keypedia.com/offices/dallas-district-office/2d1ee9ae-c44c-4494-8186-a920a69b98f9